Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
about
Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.Allelic imbalance at the HER2/TOP2A locus in breast cancerAberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer--Results from the Krakow Case-Control Study.A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsDownregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancerIdentification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerA four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trialPredictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.
P2860
Q34010867-1BA746AE-1A55-4811-9FC8-15E3F47426F1Q35663036-28AA2807-9177-4F87-ADB3-4ADF38856618Q35908315-59855C44-442D-48EB-814F-2221A65E54A5Q36544667-8CF14D60-518C-4E27-9D91-114175DFC619Q36553263-37C20907-8A58-47AB-801C-D5669CEA5854Q36907273-197333FA-ED7B-428A-A370-A24C7408A9A6Q37532636-BC498E83-B455-41B4-B222-257F5C3E1C27Q37580175-938CA1E6-05ED-4EFF-B2B2-A8EB31623B3FQ38922208-39B05866-7FCC-467D-867B-96CC0D48063EQ47793357-B040F82B-AB78-486F-93B6-0E3E100C051C
P2860
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@ast
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en-gb
type
label
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@ast
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en-gb
prefLabel
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@ast
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en-gb
P2093
P2860
P356
P1476
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer.
@en
P2093
D A Cameron
J M S Bartlett
J S Thomas
P2860
P2888
P356
10.1038/BJC.2012.232
P407
P577
2012-05-29T00:00:00Z